Stay informed with the latest litigation news. Explore now

Stabilized Transdermal Drug Delivery System - EP2299989B1

EP2299989

MYLAN
Application Number
EP09770655A
Filing Date
May 29, 2009
Status
Opposition Rejected
Apr 2, 2022
Grant Date
Jan 2, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2299989B1 was granted to Mylan on Jan 2, 2019 following the initial filing on May 29, 2009 under the application number EP09770655A . The current legal status of the patent is Opposition Rejected.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMWOct 2, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents